Skip to content

Drug interactions

Chlordiazepoxide-clidinium + Larotrectinib

Severity: Minor

Chlordiazepoxide-clidinium and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate with weak inhibitory effect, and a meaningful rise in chlordiazepoxide exposure is unlikely. Any increase in sedation would be modest.

What this interaction means in plain words

Chlordiazepoxide-clidinium and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Chlordiazepoxide-clidinium belongs to Gastrointestinal Tract; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by larotrectinib reducing chlordiazepoxide clearance.

What to do

Monitor for increased drowsiness when starting larotrectinib and lower the benzodiazepine dose if sedation develops.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Chlordiazepoxide-clidinium and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Chlordiazepoxide-clidinium with Larotrectinib?

MediHelp rates the interaction as minor. Chlordiazepoxide-clidinium and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate with weak inhibitory effect, and a meaningful rise in chlordiazepoxide exposure is unlikely. Any increase in sedation would be modest.

How serious is the interaction between Chlordiazepoxide-clidinium and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for increased drowsiness when starting larotrectinib and lower the benzodiazepine dose if sedation develops.

What other medicines interact with Chlordiazepoxide-clidinium?

MediHelp also lists interactions of Chlordiazepoxide-clidinium with, for example, Alfentanil, Alprazolam, Amobarbital. The full list is on the Chlordiazepoxide-clidinium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in